Action of the oral hypoglycemic agent 2-tetradecylglycidic acid on hepatic fatty acid oxidation and gluconeogenesis.
D000090:Acetoacetates / Q000378:metabolism; D000818:Animals; D002210:Caprylates / Q000378:metabolism; D004852:Epoxy Compounds / Q000494:pharmacology*; D004988:Ethers, Cyclic / Q000494:pharmacology*; D005227:Fatty Acids / Q000378:metabolism*; D005943:Gluconeogenesis / Q000187:drug effects*; D006885:Hydroxybutyrates / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009829:Oleic Acids / Q000378:metabolism; D010084:Oxidation-Reduction; D011422:Propionates / Q000494:pharmacology*; D051381:Rats
D000090:Acetoacetates; D002210:Caprylates; D004852:Epoxy Compounds; D004988:Ethers, Cyclic; D005227:Fatty Acids; D006885:Hydroxybutyrates; D007004:Hypoglycemic Agents; D009829:Oleic Acids; D011422:Propionates; C021756:2-tetradecylglycidic acid